Cargando…
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
Although small cell neuroendocrine carcinoma of the ureter (ureteral SCNEC) is rare, it always leads to a poor prognosis. Also, no treatment recommendation has been given for ureteral SCNEC, with only PD-1/PD-L1 inhibitors being used for its treatment. Here, we report a case of atypical symptoms of...
Autores principales: | Li, Xiaoying, Wen, Jing, Li, Hongtao, Huang, Yan, Zhou, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073532/ https://www.ncbi.nlm.nih.gov/pubmed/37035192 http://dx.doi.org/10.3389/fonc.2023.1114397 |
Ejemplares similares
-
Hyperprogression After Immunotherapy for Primary Small Cell Neuroendocrine Carcinoma of the Ureter: A Case Report
por: Qing, Defeng, et al.
Publicado: (2021) -
Collision Carcinoma Involving Small Cell Neuroendocrine Carcinoma and Squamous Cell Carcinoma of the Ureter: A Case Report and Review of the Literature
por: Xu, Sheng, et al.
Publicado: (2021) -
Imaging manifestations of small cell neuroendocrine carcinoma of the ureter
por: Chen, Guiwu, et al.
Publicado: (2023) -
Primary small cell carcinoma of the ureter with hydronephrosis: A case report
por: Sato, Ryuta, et al.
Publicado: (2019) -
Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021)